Hims & Hers Q3 2021 revenue up 79% YoY to $74.2M; raises FY2021 guidance

Hims & Hers Health, Inc.

2021-Q3 EPS reported -$0.42 revenue$187,179,000

Revenue $74.2M (+79% YoY); net loss -$15.9M vs -$5.9M prior year.
Ending subscriptions 551k (+95% YoY); AOV stable at $74.
Adjusted EBITDA -$9.8M vs -$1.6M prior year; gross margin 74% vs 76%.
Exceeded Q3 revenue guidance; raised full-year 2021 revenue outlook.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.